Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VMAC: Nesiritide vs Nitroglycerin in Decompensated CHF
NCT00270374Phase 3Completed
- Sponsor
- Scios Inc.
- Start
- Oct 1999
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial of nesiritide in acute decompensated heart failure (ADHF) (3 arms), sponsored by Scios Inc. Primary endpoints: Pulmonary Capillary Wedge Pressure at 3 hours and Self-Reported Dyspnea at 3 hours. Started Oct 1999; status: completed.
02
Drugs
nesiritide
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT00270374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270374.